PD-1:PD-L1/PD-L2通路在结核感染中的免疫作用
作者:
基金项目:

“十二五-艾滋病和病毒性肝炎等重大传染病防治”国家科技重大专项子课题(2012ZX10004501)。


The immune role of PD-1:PD-L1/PD-L2 pathway in Mycobacterium tuberculosis infection
Author:
  • ZHAN Ling-jun

    ZHAN Ling-jun

    Key Laboratory of Human Disease Comparative Medicine, Ministry of Health;Key Laboratory of Human Diseases Animal Model, State Administration of Traditional Chinese Medicine;Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Pan Jia Yuan Nan Li No. 5, Chao Yang District, Beijing 100021, China
    在期刊界中查找
    在百度中查找
    在本站中查找
  • TANG Jun

    TANG Jun

    Key Laboratory of Human Disease Comparative Medicine, Ministry of Health;Key Laboratory of Human Diseases Animal Model, State Administration of Traditional Chinese Medicine;Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Pan Jia Yuan Nan Li No. 5, Chao Yang District, Beijing 100021, China
    在期刊界中查找
    在百度中查找
    在本站中查找
  • QIN Chuan

    QIN Chuan

    Key Laboratory of Human Disease Comparative Medicine, Ministry of Health;Key Laboratory of Human Diseases Animal Model, State Administration of Traditional Chinese Medicine;Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Pan Jia Yuan Nan Li No. 5, Chao Yang District, Beijing 100021, China
    在期刊界中查找
    在百度中查找
    在本站中查找
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [22]
  • | | | |
  • 文章评论
    摘要:

    PD-1:PD-L1/PD-L2通路在肿瘤和某些感染性疾病中发挥免疫抑制作用,而在结核病中的免疫作用尚不明确。结核菌感染后,免疫细胞上PD-1:PD-L1/PD-L2通路高表达,体外实验显示:用该通路的抗体阻断后保护性T细胞增强,而体内免疫作用不明确。 PD-1与配体PD-L1结合后可能发挥免疫抑制作用,其中 PD-L1表达受Th1细胞因子调控;PD-1与配体PD-L2结合后可能发挥免疫保护作用,其中PD-L2表达受Th2型细胞因子调控。利用Cas9-CRISPR基因敲除方法分别敲除特定免疫细胞上PD-1、PD-L1和PD-L2, 可研究PD-1、PD-L1和PD-L2在结核感染中免疫作用及机制,为结核病的防控提供理论依据。

    Abstract:

    PD-1:PD-L1/PD-L2 pathway played negative immune role in most tumor and several infectious diseases, but the immune role in tuberculosis (TB) was not explicited. Since the high expression of PD-1:PD-L1/PD-L2 pathway was correlated with MTB infection both in vitro and in vivo, the in vitro negative immune role was indicated by inhibited T cell protective immune function, while the in vivo immune role was not clear. The binding of PD-1 and PD-L1 played an immunosuppression role, the expression of PD-L1 was regulated by Th1-type cytokines. The binding of PD-1 and PD-L2 played protective immune role, and the expression was regulated by Th1-type cytokines. The immune role and mechanism of PD-1, PD-L1 and PD-L2 would be investigated by Cas9-CRISPR technique, which would provide theoretical basis for the tuberculosis prevention and control.

    参考文献
    [1] Tubo NJ, Jenkins MK. CD4+ T Cells: Guardians of the Phagosome. Clinical Microbiology Reviews 2014, 27(2):200-213.
    [2] Flynn JL, Chan J. Immunology of tuberculosis. Annual review of immunology 2001, 19(1):93-129.
    [3] Urdahl KB, Shafiani S, Ernst JD. Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunology 2011, 4(3):288-293.
    [4] Hamid O, Carvajal RD. Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy. Expert Opin Biol Ther 2013, 13(6):847-861.
    [5] Sakthivel P, Gereke M, Bruder D. Therapeutic Intervention in Cancer and Chronic Viral Infections: Antibody Mediated Manipulation of PD-1/PD-L1 Interaction. Reviews on Recent Clinical Trials 7, 2012, 7(1):10-23.
    [6] Akbari O, Stock P, Singh AK, et al. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal Immunology 2009, 3(1):81-91.
    [7] Loke P, Allison JP. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proceedings of the National Academy of Sciences 2003, 100(9):5336-5341.
    [8] Javier O. Jurado IBA, Virginia Pasquinelli, et al. Programmed Death (PD)-1:PD-Ligand 1/PD-Ligand 2 Pathway Inhibits T Cell Effector Functions during Human Tuberculosis. The Journal of Immunology 2008, 181(1):116-125.
    [9] Singh A, Mohan A, Dey AB, et al. Inhibiting the Programmed Death 1 Pathway Rescues Mycobacterium tuberculosis-Specific Interferon-Producing T Cells From Apoptosis in Patients With Pulmonary Tuberculosis. Journal of Infectious Diseases 2013, 208(4):603-615.
    [10] Sakai S, Kawamura I, Okazaki T, et al. PD-1-PD-L1 pathway impairs Th1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guerin. International Immunology 2010, 22(12):915-925.
    [11] Khader S, Tousif S, Singh Y, et al. T Cells from Programmed Death-1 Deficient Mice Respond Poorly to Mycobacterium tuberculosis Infection. PLoS ONE 2011, 6(5):e19864.
    [12] Jurado JO, Alvarez IB, Pasquinelli V, et al. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol 2008, 181(1):116-125.
    [13] Zhu W, Bao R, Fan X, et al. PD-L1 Blockade Attenuated Sepsis-Induced Liver Injury in a Mouse Cecal Ligation and Puncture Model. Mediators of Inflammation 2013, 2013:1-7.
    [14] Singh AK, Stock P, Akbari O. Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy 2011, 66(2):155-162.
    [15] McNab FW, Berry MP, Graham CM, et al: Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis. European Journal of Immunology 2011, 41(7):1941-1947.
    [16] Marzo E, Vilaplana C, Tapia G, et al. Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis. Tuberculosis 2014, 94(1):55-64.
    [17] Ryoyo Ikebuchi SK, Tomohiro Okagawa, Kazumasa Yokoyama, et al. Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro. Veterinary Research 2013, 44(59):1-15.
    [18] Bhatt K, Kim A, Kim A, et al. Equivalent functions for B7.1 and B7.2 costimulation in mediating host resistance to Mycobacterium tuberculosis. Cellular Immunology 2013, 285(1-2):69-75.
    [19] Mendoza-Coronel E, Camacho-Sandoval R, Bonifaz LC, et al.PD-L2 induction on dendritic cells exposed to Mycobacterium avium downregulates BCG-specific T cell response. Tuberculosis 2011, 91(1):36-46.
    [20] Ivana B. Alvarez VP, Javier O. Jurado, Eduardo Abbate, et al. Role Played by the Programmed Death-1-Programmed Death Ligand Pathway during Innate Immunity against Mycobacterium tuberculosis. The Journal of Infectious Diseases 2010, 202(4):524-532.
    [21] Sabine J. Wölfle JS, Holger Bartz, Aline Sähr, et al. PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur J Immunol, 2011, 41(2):413-424.
    [22] Elizabeth Mendoza-Coronela RC-S, Laura C. Bonifazb, Yolanda López-Vidala. PD-L2 induction on dendritic cells exposed to Mycobacterium avium downregulates BCG-specific T cell response. Tuberculosis 2011, 91(1):36-46.
    相似文献
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

占玲俊,唐军,秦川. PD-1:PD-L1/PD-L2通路在结核感染中的免疫作用[J].中国比较医学杂志,2015,25(7):74~76.

复制
分享
文章指标
  • 点击次数:4589
  • 下载次数: 2149
  • HTML阅读次数: 0
  • 引用次数: 0
历史
  • 最后修改日期:2015-06-24
  • 在线发布日期: 2015-07-28
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭